Pharmafile Logo
Pharmafocus logo
Advanced Search

Roche

Showing 15 posts of 710 posts found.

astrazeneca image

AZ bullish on its future – but analysts wary

January 15, 2014
Sales and Marketing AstraZeneca, Roche, analysts, jp morgan

AstraZeneca is combating fears over its long-term future by assuring investors that it has the pipeline and the tenacity to …

News
nhs_parliament_2_1

MPs ‘surprised and concerned’ over data transparency

January 3, 2014
Medical Communications, Sales and Marketing Cochrane, Godlee, Goldacre, Roche, Tamiflu, transparency

News
Merck image

Merck’s melanoma vaccine impresses

November 19, 2013
Research and Development, Sales and Marketing MK-3475, Merck, Roche, melanoma

Merck has posted impressive results for its new melanoma vaccine MK-3475 as it looks to vie for a place in …

News
Roche image

Roche signs $17 million immatics deal

November 15, 2013
Research and Development, Sales and Marketing Cancer, Roche, immatics, lung, prostate

Roche is to pay German biotech company immatics $17 million to collaborate on the search for vaccines in various cancers, …

News
Roche image

ImmunoGen stops cancer trial

November 6, 2013
Research and Development, Sales and Marketing Cancer, IMGN901, Immunogen, Roche

Roche subsidiary ImmunoGen has abandoned a Phase II trial into small-cell lung cancer (SCLC) after deciding that it was not …

News
roche image

Roche strikes $550 million antibiotics deal

November 4, 2013
Research and Development, Sales and Marketing Antibiotics, Roche, WHO

News
Roche logo

FDA approves Roche’s new leukemia drug

November 4, 2013
Research and Development, Sales and Marketing Arzerra, CLL, FDA, GSK, Roche, chronic lymphocytic leukaemia

News
samsung image

Samsung signs biologics deal with Roche

October 25, 2013
Manufacturing and Production Korea, Roche, Samsung

Roche is leaving nothing to chance in its pursuit of the biologics drug market, adding to its internal investment programme …

News
Herceptin image

The new paradigm in oncology drug marketing

October 21, 2013
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Herceptin, Roche, marketing, oncology

Twenty years ago drugs to treat cancer were made up of chemotherapy agents which are essentially ‘blunt tools’ against the …

Feature
Roche image

Roche rules out merger talk

October 18, 2013
Sales and Marketing Cancer, Herceptin, Novartis, Roche, merger

Roche has dismissed talk of merging with fellow Swiss manufacturer Novartis as it revealed its results for the last three …

News
Roche image

Roche poised to get even bigger in biomanufacturing

October 15, 2013
Manufacturing and Production Jobs, Merck, Roche, cuts

Roche plans to invest a massive 800 million Swiss francs ($882m) over the next five years to increase manufacturing capacity …

News

Global cancer crisis flagged in report

October 3, 2013
Medical Communications, Research and Development, Sales and Marketing IPRI, Roche, wprld prevention alliance

A new report advocates the formation of a major industry-backed initiative to tackle the world’s growing cancer burden.  Sponsored by …

News
mabthera image

NICE U-turn on MabThera

October 3, 2013
Sales and Marketing MabThera, NHS, NICE, Roche

NICE is thinking about recommending Roche’s MabThera for a rare autoimmune condition – a move which represents a partial victory …

News
Perjeta image

Perjeta becomes first approved drug for early breast cancer

October 1, 2013
Sales and Marketing FDA, Herceptin, Perjeta, Roche

Roche’s Perjeta has become the first preoperative breast cancer drug to be authorised by the FDA after it was granted …

News

Eisai restates Halaven’s challenge to Roche’s Xeloda

September 30, 2013
Research and Development, Sales and Marketing ECC, Halaven, Roche, Xeloda

Eisai has updated research on its breast cancer drug Halaven in a renewed bid to establish the treatment as a …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025